MedTrace Logo

Study of Efficacy, Pharmacokinetics, and Safety of Bolus Maintenance Doses of Org 9426 (Study P05976)(COMPLETED)

NCT00984633 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2015-05-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy, pharmacokinetics, and safety of Org 9426 in maintenance of muscle relaxation in adult subjects undergoing general elective surgery.

Conditions

  • Muscle Relaxation

Interventions

DRUG

Rocuronium bromide (Org 9426)

0.6 mg/kg injection intubation dose

DRUG

Rocuronium bromide (Org 9426)

0.9 mg/kg injection intubation dose

DRUG

Sevoflurane

0.5-2.0% intravenous maintenance anesthesia

DRUG

Propofol

4-10 mg/kg/hr maintenance anesthesia

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Primary Completion
2003-12-31
Completion
2003-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00984633 on ClinicalTrials.gov